Come up with a name for your new list and we'll add to it:
OncoGenex Pharmaceuticals raised a round of funding on , . Investors include
Research Corporation Technologies.
OncoGenex Pharmaceuticals (NASDAQ: OGXI) is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients.…